Lung Cancer | Optimizing Biomarker-Based Decision-Making for Patients with Non-Small Cell Lung Cancer with EGFR Mutations or with Other Oncogene-Addicted Lung Cancers

Featuring perspectives from Drs Marc Ladanyi, Andrew McKenzie and Joel Neal, including the following topics: Introduction (0:00) Role of Genomic Profiling; New Developments in Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation (0:49) Case: A woman in her early 60s with NSCLC and an EGFR exon 19 deletion — Andrew J McKenzie, PhD (30:40) Case: A man in his early 50s with metastatic lung adenocarcinoma and an EGFR exon 20 mutation — Atif Hussein, MD, MMM (35:04) Case: A man in his early 50s with RET positive NSCLC — Joel W Neal, MD, PhD (48:48) Case: A woman in her mid-60s with metastatic NSCLC and a HER2 exon 20 insertion — Dr Neal  CME information and select publications